Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Tight-control Strategy With and Without Rosuvastatin on Progression of Subclinical Carotid and Coronary Atherosclerosis in Psoriatic Arthritis- a Randomized Controlled Study

NCT04176978 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT04176978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04176978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Tight-control Strategy With and Without Rosuvastatin on Progression of Subclinical Carotid and Coronary Atherosclerosis in Psoriatic Arthritis- a Randomized Controlled Study
Lead sponsor
Chinese University of Hong Kong
Phase
Not applicable
Overall status
Withdrawn
Start date
April 1, 2021
Completion date
December 31, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, psoriatic arthritis